BIRC5 and colorectal cancer: Endo et al (9) proposed that the decrease of Smac/DIABLO expression is an independent factor of poor prognosis for colorectal cancer patients, while other studies have indicated that survivin may be a marker for tumor progression and prognosis (5,31,32).